Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 38

Results: 10

Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5241, doi. 10.1038/onc.2010.264
By:
- Holgren, C.;
- Dougherty, U.;
- Edwin, F.;
- Cerasi, D.;
- Taylor, I.;
- Fichera, A.;
- Joseph, L.;
- Bissonnette, M.;
- Khare, S.
Publication type:
Article
Still embedded together binding to membranes regulates Bcl-2 protein interactions.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5221, doi. 10.1038/onc.2010.283
By:
- Leber, B.;
- Lin, J.;
- Andrews, D. W.
Publication type:
Article
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5286, doi. 10.1038/onc.2010.267
By:
- Cantelmo, A. R.;
- Cammarota, R.;
- Noonan, D. M.;
- Focaccetti, C.;
- Comoglio, P. M.;
- Prat, M.;
- Albini, A.
Publication type:
Article
Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5231, doi. 10.1038/onc.2010.286
By:
- Munro, A. F.;
- Cameron, D. A.;
- Bartlett, J. M. S.
Publication type:
Article
The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5265, doi. 10.1038/onc.2010.280
By:
- Santos, J.;
- González-Sánchez, L.;
- Villa-Morales, M.;
- Ors, I.;
- López-Nieva, P.;
- Vaquero, C.;
- González-Gugel, E.;
- Fernández-Navarro, P.;
- Roncero, A. M.;
- Guenet, J.-L.;
- Montagutelli, X.;
- Fernández-Piqueras, J.
Publication type:
Article
Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5322, doi. 10.1038/onc.2010.278
By:
- Bengoechea-Alonso, M. T.;
- Ericsson, J.
Publication type:
Article
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5299, doi. 10.1038/onc.2010.261
By:
- Tang, D.;
- Kang, R.;
- Cheh, C.-W.;
- Livesey, K. M.;
- Liang, X.;
- Schapiro, N. E.;
- Benschop, R.;
- Sparvero, L. J.;
- Amoscato, A. A.;
- Tracey, K. J.;
- Zeh, H. J.;
- Lotze, M. T.
Publication type:
Article
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5254, doi. 10.1038/onc.2010.268
By:
- Ye, X.;
- Li, Y.;
- Stawicki, S.;
- Couto, S.;
- Eastham-Anderson, J.;
- Kallop, D.;
- Weimer, R.;
- Wu, Y.;
- Pei, L.
Publication type:
Article
BRCA1-IRIS overexpression abrogates UV-induced p38MAPK/p53 and promotes proliferation of damaged cells.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5274, doi. 10.1038/onc.2010.262
By:
- Chock, K.;
- Allison, J. M. S.;
- ElShamy, W. M.
Publication type:
Article
The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction.
Published in:
Oncogene, 2010, v. 29, n. 38, p. 5311, doi. 10.1038/onc.2010.265
By:
- Nagasaka, K.;
- Pim, D.;
- Massimi, P.;
- Thomas, M.;
- Tomaić, V.;
- Subbaiah, V. K.;
- Kranjec, C.;
- Nakagawa, S.;
- Yano, T.;
- Taketani, Y.;
- Myers, M.;
- Banks, L.
Publication type:
Article